Inactive Partial Small Business Set-Aside (FAR 19.5)

See attached RFP for solicitation details. Attached are the government's responses to all questions received for this RFP as well as the DCR SP Network Overview.

Inactive Partial Small Business Set-Aside (FAR 19.5)

Contracts awarded from this solicitation shall provide the capacity and capability for a broad range of services necessary to support and conduct biomedical research in support of the NIAID mission an... Contracts awarded from this solicitation shall provide the capacity and capability for a broad range of services necessary to support and conduct biomedical research in support of the NIAID mission and the management of activities specified under the Statement of Work and associated Task Orders. Services include expanding the breadth and depth of knowledge in all areas of infectious, immunologic, and allergic diseases and developing flexible domestic and international research capacities to respond appropriately to emerging and re?emerging disease threats both domestic and foreign. These capabilities will allow NIAID to rapidly and efficiently address research program needs. This Indefinite Delivery Indefinite Quantity (IDIQ) contract shall be administered and used primarily to support NIAID’s Division of Clinical Research, Division of Intramural Research, and Vaccine Research Center. However, other NIAID programs may initiate Task Orders under this IDIQ as necessary to help accomplish their mission. Offerors are expected to have the expertise and personnel to meet the requirements of the project and be able to demonstrate their capability to perform this requirement. The contract will support tasks in the following areas: Clinical Trials and Human Subject Research Chemistry Manufacturing and Controls (CMC) Activities Non?Clinical Research: Animal Studies Analytics, Bioinformatics, Computational Biology and Biostatistical Services Storage and Repository Regulatory and Quality Assurance Services Basic and Mechanistic Studies and Specialized Services The anticipated start date is on/or about May 1, 2021.